NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Free peptide testing

Ordered Tirzepatide from Xingtai Jiachuang Technology? Mail in a sample (US only) and let us test it for free.

Test my supply
+2 more ↓
77%
Finnrick rating
#179 of 262 Tirzepatide vendors
22 of 29 classifiable tests passed
customers 4.5★ (31)
methodology · Purity focus
Finnrick analysis · Tirzepatide

Xingtai Jiachuang Technology's tirzepatide record is mixed: earlier purity misses include 94.67%, 98.8%, and one 0 mg identity failure. Later results recovered to clean identity/purity/fill, but sparse batch IDs remain a caveat.

methodology →
vendor intelligence report
Vendor Intelligence Report: Xingtai Jiachuang Technology

Registry and platform records recast Jiachuang as a new small Hebei entity, not the established facility its marketing describes. The report follows a 35.com storefront, Hong Kong WhatsApp channels, copied GlobalSources boilerplate, and Xingtai cluster leads.

28 pages7 risk factors assessed3 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.06
91%
7
2
Tirzepatideselected
$0.45
77%
29
3
Retatrutide
$0.90
74%
19
4
BPC-157
$0.45
44%
3
5
Tesamorelin
$3.05
40%
10
7
Ipamorelin
$0.80
-
0
8
PT-141
$0.50
-
0
9
TB-500
$1.10
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%8 Jul 2025: 64%23 Oct 2025: 75%15 Jan 2026: 78%26 Jan 2026: 80%26 Jan 2026: 80%26 Jan 2026: 81%29 Jan 2026: 77%29 Jan 2026: 78%2 Feb 2026: 74%2 Feb 2026: 70%18 Feb 2026: 71%18 Feb 2026: 72%25 Feb 2026: 73%26 Feb 2026: 74%4 Mar 2026: 75%6 Mar 2026: 76%6 Mar 2026: 77%6 Mar 2026: 74%6 Mar 2026: 75%10 Mar 2026: 72%13 Mar 2026: 73%3 Apr 2026: 74%5 May 2026: 75%20 May 2026: 76%22 Jun 2026: 77%13 Jul 2026: 78%13 Jul 2026: 75%20 Jul 2026: 76%16 Sep 2026: 77%29 Sep 2026: current 77%64%78%77%Jul 25Sep 26
Showing Tirzepatide tests only
Free peptide testing

Ordered Tirzepatide from Xingtai Jiachuang Technology? Mail in a sample (US only) and let us test it for free.

Test my supply
Xingtai Jiachuang Technology Tirzepatide test history
COA-backed lab tests
1-10 of 29

About Xingtai Jiachuang Technology test results from Finnrick

Xingtai Jiachuang Technology is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 5 peptides and 68 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Xingtai Jiachuang Technology peptides in this dataset are BPC-157 (3 tests), GHK-Cu (7 tests) and Retatrutide (19 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 68 recent tests. It also includes 1 correction related to this vendor.

Corrections
2026-07-26
Finnrick data entry
The reported value of 15 mg was inadvertently carried over from a previous Certificate of Analysis (COA) associated with a different sample. This value did not correspond to sample 7f5fe47 and was included in error. The incorrect information has been removed, and the system has been updated to correctly reference the original label claim of 60 mg for this sample.
Free peptide testing

Ordered Tirzepatide from Xingtai Jiachuang Technology? Mail in a sample (US only) and let us test it for free.

Test my supply